Drugs / Bifidobacterium Bifidum Oral Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05620004 | Nov 2021 → Dec 2023 | hepatocellular carcinoma | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium Bifidum Oral Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05620004 ↗ |
| Route | Oral | “treated with oral bifidobacterium” NCT05620004 ↗ |